Update to CredibleMeds List

Re: Revision to the QTdrugs List

We are writing to inform you that Sertindole, a drug used in the treatment of schizophrenia, has been moved from the Possible Risk of Torsades de Pointes (TdP) category to the Known Risk of TdP category because of newly available evidence that it is associated with TdP.

Also, we hope you will try AZCERT’s web-based decision support program, MedSafety Scan®, available at MedSafetyScan.org for open-access use during the COVID-19 pandemic. The program can help healthcare providers quickly assess a patient’s risk of QT prolongation and detect potentially dangerous drug-drug interactions.

The features of MedSafety Scan are described in detail in a recent article published in Trends in Cardiovascular Medicine titled Assisted prescribing: Clinical decision support with MedSafety Scan.

Ray Woosley and the Scientific Review Committee

Scientific Review Committee Raymond L. Woosley, MD, PhD
Klaus Romero, MD, MS
C.Will Heise, MD
Tyler Gallo, PharmD
Jared Tate, PharmD
David Woosley, MPH

November 20, 2023 No Comments

Leading researchers gather at St George’s University of London, to showcase a portfolio of projects funded by Cardiac Risk in the Young

Focus group for patients with DCM and ARVC

October 6, 2023 No Comments

On the 29th of September, a focus group for patients with dilated and arrhythmogenic cardiomyopathy has been organized by CRY and by Dr

myheart enews-Jun to Sept 2023

October 2, 2023 No Comments

Dear myheart members, In this e-newsletter you can find information about: Read the full enews here. Subscribe to myheart enews here to receive latest myheart and CRY updates.

Update to CredibleMeds List

December 17, 2020

Re: Revision to the QTdrugs List

More to explorer

Focus group for patients with DCM and ARVC

myheart enews-Jun to Sept 2023

myheart Coordinator